GPT2 and cancer: Therefore, the inhibition of glutamine uptake by the glutamine transporter (ASCT2), as well as the inhibition of glutaminase, GDH, GOT1 and GPT2, seem to all be good strategies to decrease the replenishment of intermediates in the TCA cycle and, consequently, cancer cell proliferation.